Elisabet Cuyas
Girona, CT 17190, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101 publications
Cellular Senescence in the Absence of Galactic Cosmic-Ray Muons.
Journal: Aging and disease
Published: January 08, 2026
Silibinin is a natural molecular glue that inhibits PD-L1 glycomaturation.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 08, 2025
Mitochondrial priming in therapy-induced senescence: implications for CAR-T/NK immunosenolytic therapy.
Journal: Frontiers in immunology
Published: August 29, 2025
Fatty acid synthesis therapy-induced senescence (FASTIS) in cancer cells.
Journal: Cell death & disease
Published: August 12, 2025
Metabolic hallmarks of trastuzumab resistance.
Journal: Expert opinion on therapeutic targets
Published: July 11, 2025
Mitochondrial bioenergetics-SASP crosstalk determines senolytic efficacy in therapy-induced senescence.
Journal: Cell death discovery
Published: February 22, 2025
Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment.
Journal: NAR cancer
Published: October 17, 2024
Fatty acid synthase (FASN) inhibition cooperates with BH3 mimetic drugs to overcome resistance to mitochondrial apoptosis in pancreatic cancer.
Journal: Neoplasia (New York, N.Y.)
Published: September 05, 2024
Mitochondrial priming and response to BH3 mimetics in "one-two punch" senogenic-senolytic strategies.
Journal: Cell death discovery
Published: August 12, 2024
Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity.
Journal: Cell death discovery
Published: July 04, 2024
Silibinin is a suppressor of the metastasis-promoting transcription factor ID3.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 21, 2023
Last Updated: 09/26/2026